Based on the forecasted data for malignant neoplasms mortality in Australia, the standardised rates are expected to decrease steadily from 183.7 deaths per hundred thousand persons in 2024 to 176.6 in 2028. Comparing 2024 to 2025, the year-on-year variation shows a decrease of approximately 1.03%. From 2025 to 2026, the decline is around 0.99%, followed by a 1.00% decrease from 2026 to 2027, and a 0.90% drop from 2027 to 2028.
Regarding long-term trends, between 2023 and 2028, the compound annual growth rate (CAGR) exhibits an average yearly reduction of about 1.00%. This consistent downward trend reflects ongoing improvements in early detection, treatment, public health initiatives, and perhaps lifestyle changes.
Future trends to watch for include advancements in medical technology, continued research in oncology, potential policy changes impacting healthcare, and evolving public health strategies aimed at reducing cancer incidence and mortality. Monitoring these factors will be crucial in understanding and possibly accelerating the decline in mortality rates.
